Free Trial

Evoke (LON:EVOK) Trading 16.4% Higher - Here's Why

Evoke logo with Consumer Cyclical background

Evoke plc (LON:EVOK - Get Free Report)'s share price rose 16.4% during trading on Tuesday . The stock traded as high as GBX 45.90 ($0.60) and last traded at GBX 44 ($0.58). Approximately 21,217,725 shares were traded during mid-day trading, an increase of 646% from the average daily volume of 2,844,839 shares. The stock had previously closed at GBX 37.80 ($0.49).

Analyst Ratings Changes

Separately, Jefferies Financial Group restated a "buy" rating and set a GBX 140 ($1.83) price target on shares of Evoke in a report on Monday, December 16th.

Get Our Latest Analysis on Evoke

Evoke Trading Down 4.9 %

The company has a 50-day moving average of GBX 62.59 and a 200-day moving average of GBX 62.10. The firm has a market capitalization of £207.38 million, a P/E ratio of -1.16 and a beta of 0.84.

Evoke (LON:EVOK - Get Free Report) last announced its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. Research analysts predict that Evoke plc will post 12.7648305 EPS for the current year.

Insider Activity

In other Evoke news, insider Jonathan (Jon) Mendelsohn purchased 200,000 shares of the company's stock in a transaction on Monday, March 31st. The shares were purchased at an average cost of GBX 48 ($0.63) per share, with a total value of £96,000 ($125,654.45). Also, insider Andrea Gisle Joosen purchased 14,572 shares of the business's stock in a transaction on Tuesday, January 28th. The shares were acquired at an average price of GBX 70 ($0.92) per share, for a total transaction of £10,200.40 ($13,351.31). Insiders own 27.00% of the company's stock.

About Evoke

(Get Free Report)

Recommended Stories

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines